Olema Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2025 | 6.84 M | $25.73 M | -8.38% | 11.65% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2025 | 6.74 M | $25.35 M | -7.72% | 11.48% |
| BVF INC/IL | 05/15/2025 | 5.30 M | $19.91 M | -7.35% | 9.02% |
| DEEP TRACK CAPITAL, LP | 05/15/2025 | 3.44 M | $12.95 M | 0.00% | 5.86% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2025 | 3.21 M | $12.07 M | 0.00% | 5.46% |
| BIOIMPACT CAPITAL LLC | 05/15/2025 | 2.93 M | $11.02 M | 0.61% | 4.99% |
| BLACKROCK, INC. | 05/02/2025 | 3.82 M | $14.37 M | 0.86% | 4.47% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 3.01 M | $11.33 M | 1,000.44% | 3.53% |
| VANGUARD GROUP INC | 05/09/2025 | 2.87 M | $10.80 M | 6.95% | 3.36% |
| 05/15/2025 | 1.93 M | $7.26 M | 0.00% | 3.29% | |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 1.88 M | $7.07 M | -0.23% | 2.20% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.87 M | $7.04 M | 11.25% | 2.19% |
| VIVO CAPITAL, LLC | 05/12/2025 | 1.51 M | $5.66 M | 0.00% | 1.76% |
| WOODLINE PARTNERS LP | 05/15/2025 | 1.48 M | $5.56 M | 8.87% | 1.73% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 1.47 M | $5.54 M | -3.40% | 1.73% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 1.44 M | $5.42 M | -60.73% | 1.69% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 978.85 K | $3.68 M | -0.04% | 1.67% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 1.32 M | $4.96 M | -1.02% | 1.54% |
| UBS GROUP AG | 05/13/2025 | 1.15 M | $4.33 M | 105.38% | 1.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.08 M | $4.07 M | 16.95% | 1.27% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 908.55 K | $3.42 M | 4.99% | 1.06% |
| STATE STREET CORP | 05/15/2025 | 865.56 K | $3.25 M | -53.40% | 1.01% |
| CANDRIAM S.C.A. | 05/14/2025 | 850.52 K | $3.20 M | -45.18% | 1.00% |
| PIER CAPITAL, LLC | 05/13/2025 | 817.96 K | $3.08 M | 200.31% | 0.96% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 741.33 K | $2.79 M | 93.60% | 0.87% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 05/13/2025 | 533.11 K | $2.19 M | 0.00% | 0.62% |
| MORGAN STANLEY | 05/15/2025 | 451.69 K | $1.70 M | -55.91% | 0.53% |
| NORTHERN TRUST CORP | 05/13/2025 | 418.09 K | $1.57 M | -1.35% | 0.49% |
| AMERIPRISE FINANCIAL INC | 05/14/2025 | 399.80 K | $1.50 M | -11.10% | 0.47% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 368.10 K | $1.38 M | 89.99% | 0.43% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 349.02 K | $1.31 M | 4.83% | 0.41% |
| 05/12/2025 | 344.30 K | $1.29 M | 100.00% | 0.40% | |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 325.00 K | $1.22 M | 100.00% | 0.38% |
| MARSHALL WACE, LLP | 05/15/2025 | 319.95 K | $1.20 M | 65.83% | 0.37% |
| JPMORGAN CHASE & CO | 05/12/2025 | 286.93 K | $1.08 M | 78.50% | 0.34% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 191.99 K | $721.90 K | 108.70% | 0.33% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 04/10/2025 | 242.49 K | $911.75 K | 14.25% | 0.28% |
| HIGHVISTA STRATEGIES LLC | 05/15/2025 | 212.19 K | $797.82 K | 0.00% | 0.25% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 05/14/2025 | 175.45 K | $659.68 K | 1,498.47% | 0.21% |
| BARCLAYS PLC | 05/15/2025 | 153.10 K | $576.00 K | 33.27% | 0.18% |
| 05/15/2025 | 100.00 K | $376.00 K | 100.00% | 0.17% | |
| JANE STREET GROUP, LLC | 05/19/2025 | 138.55 K | $520.96 K | 216.78% | 0.16% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 138.00 K | $518.88 K | 55.06% | 0.16% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 93.67 K | $352.20 K | 260.45% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 131.99 K | $496.30 K | 2.59% | 0.15% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 113.02 K | $424.95 K | -89.98% | 0.13% |
| DANA INVESTMENT ADVISORS, INC. | 05/15/2025 | 112.95 K | $424.71 K | 22.72% | 0.13% |
| VICTORY CAPITAL MANAGEMENT INC | 05/02/2025 | 92.31 K | $347.09 K | -0.85% | 0.11% |
| WALLEYE CAPITAL LLC | 05/14/2025 | 87.71 K | $329.77 K | 30.89% | 0.10% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 74.92 K | $281.70 K | 0.00% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Olema Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 178 institutional investors and hedge funds held shares of Olema Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Bain Capital Life Sciences Investors, LLC: 6.84 M
Paradigm Biocapital Advisors LP: 6.74 M
BVF INC/IL: 5.3 M
BlackRock, Inc.: 3.82 M
Deep Track Capital, LP: 3.44 M
Logos Global Management LP: 3.21 M
77.13% of Olema Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 69.33 M shares in the last 24 months. This purchase volume represents approximately $316.83 M in transactions.